Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Farmers Insurance
Fish and Richardson
Medtronic
Baxter
Healthtrust
Boehringer Ingelheim
Cipla

Generated: July 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020604

« Back to Dashboard

NDA 020604 describes SEROSTIM LQ, which is a drug marketed by Emd Serono and is included in one NDA. It is available from one supplier. Additional details are available on the SEROSTIM LQ profile page.

The generic ingredient in SEROSTIM LQ is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.
Summary for 020604
Tradename:SEROSTIM LQ
Applicant:Emd Serono
Ingredient:somatropin recombinant
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020604
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604 NDA EMD Serono, Inc. 44087-0004 N 44087-0004-7
SEROSTIM LQ somatropin recombinant INJECTABLE;SUBCUTANEOUS 020604 NDA EMD Serono, Inc. 44087-0004 N 44087-0004-7

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength6MG/VIAL
Approval Date:Aug 23, 1996TE:BXRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/VIAL
Approval Date:Aug 23, 1996TE:BXRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength4MG/VIAL
Approval Date:Jul 25, 1997TE:RLD:No

Expired US Patents for NDA 020604

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-001 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-003 Jul 25, 1997 ➤ Sign Up ➤ Sign Up
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-004 Sep 6, 2001 ➤ Sign Up ➤ Sign Up
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-002 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
US Army
Fuji
Cipla
Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.